The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
Open accessAbstract
BACKGROUND: Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter-defibrillator (ICD) is frequent despite antiarrhythmic drug therapy. The most effective approach to management of this problem is uncertain. METHODS: We conducted a multicenter, randomized, controlled trial involving patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite the use of antiarrhythmic drugs. Patients were randomly assigned to receive either catheter ablation (ablation group) with continuation of baseline antiarrhythmic medications or escalated antiarrhythmic drug therapy (escalated-therapy group). In the escalated-therapy group, amiodarone was initiated if another agent had been used previously. The dose of amiodarone was increased if it had been less than 300 mg per day or mexiletine was added if the dose was already at least 300 mg per day. The primary outcome was a composite of death, three or more documented episodes of ventricular tachycardia within 24 hours (ventricular tachycardia storm), or appropriate ICD shock. RESULTS: Of the 259 patients who were enrolled, 132 were assigned to the ablation group and 127 to the escalated-therapy group. During a mean (±SD) of 27.9±17.1 months of follow-up, the primary outcome occurred in 59.1% of patients in the ablation group and 68.5% of those in the escalated-therapy group (hazard ratio in the ablation group, 0.72; 95% confidence interval, 0.53 to 0.98; P=0.04). There was no significant between-group difference in mortality. There were two cardiac perforations and three cases of major bleeding in the ablation group and two deaths from pulmonary toxic effects and one from hepatic dysfunction in the escalated-therapy group. CONCLUSIONS: In patients with ischemic cardiomyopathy and an ICD who had ventricular tachycardia despite antiarrhythmic drug therapy, there was a significantly lower rate of the composite primary outcome of death, ventricular tachycardia storm, or appropriate ICD shock among patients undergoing catheter ablation than among those receiving an escalation in antiarrhythmic drug therapy. (Funded by the Canadian Institutes of Health Research and others; VANISH ClinicalTrials.gov number, NCT00905853.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,607
Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065457 · Cited by 959
Kuck, K.-H., Schaumann, A., Eckardt, L., Willems, S., Ventura, R., Delacrétaz, E., Pitschner, H.-F., Kautzner, J., Schumacher, B., & Hansen, P. S. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61755-4 · Cited by 799
Wathen, M. S., DeGroot, P. J., Sweeney, M. O., Stark, A. J., Otterness, M. F., Adkisson, W. O., Canby, R. C., Khalighi, K., Machado, C., Rubenstein, D. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000145610.64014.e4 · Cited by 775
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
Aliot, E. M., Stevenson, W. G., Almendral-Garrote, J. M., Bogun, F., Calkins, C. H., Delacretaz, E., Della Bella, P., Hindricks, G., Jaïs, P., Josephson, M. E., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.04.030 · Cited by 770
Self-citationSaxon, L. A., Hayes, D. L., Gilliam, F. R., Heidenreich, P. A., Day, J., Seth, M., Meyer, T. E., Jones, P. W., & Boehmer, J. P. (2010) · Circulation · doi:10.1161/circulationaha.110.960633 · Cited by 515
Tung, R., Vaseghi, M., Frankel, D. S., Vergara, P., Di Biase, L., Nagashima, K., Yu, R., Vangala, S., Tseng, C.-H., Choi, E.-K., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.036 · Cited by 499
Self-citationPrevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Europace · doi:10.1093/europace/euu194 · Cited by 327
Self-citationRandomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
The CASCADE Investigators (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90673-z · Cited by 308
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.024 · Cited by 288
Self-citationA Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-Defibrillators
Wilkoff, B. L., Ousdigian, K. T., Sterns, L. D., Wang, Z. J., Wilson, R. D., & Morgan, J. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.037 · Cited by 242
Self-citationDunbar, S. B., Dougherty, C. M., Sears, S. F., Carroll, D. L., Goldstein, N. E., Mark, D. B., McDaniel, G., Pressler, S. J., Schron, E., Wang, P., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31825d59fd · Cited by 221
Piccini, J. P., Berger, J. S., & O'Connor, C. M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp100 · Cited by 198
Bokhari, F., Newman, D., Greene, M., Korley, V., Mangat, I., & Dorian, P. (2004) · Circulation · doi:10.1161/01.cir.0000134957.51747.6e · Cited by 181
Population pharmacokinetics of long-term oral amiodarone therapy
Pollak, P. T. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.107047 · Cited by 102
Raitt, M. H., Klein, R. C., Wyse, D. G., Wilkoff, B. L., Beckman, K. J., Epstein, A. E., Coromilas, J., Friedman, P. L., Martins, J. B., Ledingham, R. B., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00015-8 · Cited by 36
Dev, S., Peterson, P. N., Wang, Y., Curtis, J. P., Varosy, P. D., & Masoudi, F. A. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.023 · Cited by 12
Cited by
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,140
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
Self-citationHalvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., De Hert, S., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,141
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H., Darrieux, F. C. C., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.05.007 · Cited by 846
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 724
Self-citation
Metadata
- Authors
- Sapp, J. L., Wells, G. A., Parkash, R., Stevenson, W. G., Blier, L., Sarrazin, J.-F., Thibault, B., Rivard, L., Gula, L., Leong-Sit, P., Essebag, V., Nery, P. B., Tung, S. K., Raymond, J.-M., Sterns, L. D., Veenhuyzen, G. D., Healey, J. S., Redfearn, D., Roux, J.-F., & Tang, A. S. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-07-14
- Volume
- 375
- Issue
- 2
- Pages
- 111-121
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2345572214
- Cited by
- 863
- References
- 21
- FWCI
- 65.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.